Holen Sie sich die Stockscreener-App
1.98
10.81%
-0.24
Handel nachbörslich:
1.97
-0.01
-0.51%
Finanzdaten der Mersana Therapeutics Inc-Aktie (MRSN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
13.61%
9.245
|
10.70 | 7.698 | 10.65 | 7.802 |
Operating Expenses
|
5.86%
30.25
|
32.13 | 51.64 | 67.16 | 65.60 |
| Interest Income/Expense |
4.39%
1.002
|
1.048 | 1.017 | 1.025 | 0.983 |
| Benefits Costs and Expenses |
5.60%
28.55
|
30.25 | - | - | 63.97 |
| Costs And Expenses |
5.60%
28.55
|
30.25 | 51.64 | 67.16 | 63.97 |
| Operating Income/Loss |
1.99%
-21.00
|
-21.43 | -43.94 | -56.50 | -57.80 |
| Nonoperating Income/Loss |
9.98%
1.695
|
1.883 | 2.285 | 2.194 | 1.638 |
| Income/Loss From Continuing Operations Before Tax |
1.22%
-19.31
|
-19.54 | 7.698 | -54.31 | -56.16 |
| Income/Loss From Continuing Operations After Tax |
1.22%
-19.31
|
-19.54 | -41.66 | -54.31 | -56.16 |
|
Net Income/Loss
|
1.22%
-19.31
|
-19.54 | -41.66 | -54.31 | -56.16 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
7,904%
121.42
|
1.517 | 120.52 | 115.61 | 107.51 |
| Diluted Average Shares |
7,904%
121.42
|
1.517 | 120.52 | 115.61 | 107.51 |
| Basic Earnings Per Share |
6.67%
-0.16
|
-0.15 | -0.35 | -0.47 | -0.52 |
| Diluted Earnings Per Share |
6.67%
-0.16
|
-0.15 | -0.35 | -0.47 | -0.52 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):